Using this established model of NF2, we tested the hypothesis that chemopreventative COX-2 inhibition attenuates spontaneous schwannomagenesis or sensorineural hearing loss (SNHL). This evidence concerns the gene PTGS2 and sensorineural hearing loss disorder.